TNFSF11 and plasma cell myeloma: Myeloma cells can stimulate production of several cytokines such as RANKL, macrophage inflammatory protein-1α (MIP-1α), and monocyte chemoattractant protein-1 (MCP-1) and thus enhance osteoclast differentiation and bone resorption activity 4, 6.